First Blood-Based Lung Cancer EGFR Test Gets FDA Green Light
This article was originally published in The Pink Sheet Daily
Executive Summary
Roche's cobas EGFR Mutation Test v2 liquid biopsy test is approved to detect genetic mutations linked to drug response in patients with non-small cell lung cancer treated with Tarceva.